Molecular Dynamics Simulations of Glycocholate−Oleic Acid Mixed Micelle Assembly
Source abstract
Abstract
We have applied a molecular dynamics (MD) method to investigate the aggregation behavior and physicochemical properties of bile salt as well as bile salt/fatty acid mixed micelles. Local atomic density profiles from the center of the micelles confirm that the self-assembly of the trihydroxy bile salt, glycocholate, is largely driven by hydrophobic aggregation of the nonpolar beta-faces of the steroid backbones. Additional association occurs between neighboring monomers through hydrogen-bonding interactions. The average micellar aggregation number for glycocholate at 37 degrees C with a background salt concentration of 150 mM is shown to be 8.5 molecules per micelle, while the critical micelle concentration (cmc) is 3.1 mM. The good agreement of these results with experimental values illustrates that a MD approach is useful to study mixed micelles of bile salts and fatty acids, critical to the understanding of oral lipid-based formulations. The aggregation behavior and colloidal structure of such micelles are simulated and presented in this article.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Drug Transport and Resistance Mechanisms · Surfactants and Colloidal Systems · Drug Solubulity and Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical Sciences, Mercer University, Atlanta, Georgia 30341
Department of Chemistry, Emory University, Atlanta, Georgia 30322
References (26)
Show source-provided references
1. Porter C. J. · Nat. Rev. Drug Discovery · 2007 · 6 · 23110.1038/nrd2197 ↗
2. Pouton C. W. · Eur. J. Pharm. Sci. · 2006 · 29 · 27810.1016/j.ejps.2006.04.016 ↗
3. Porter C. J. · Adv. Drug Delivery Rev. · 2001 · 50 · S12710.1016/S0169-409X(01)00182-X ↗
4. Hauss, D. J.Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs;Informa Healthcare:New York, 2007; ppxii,339; pp207−241,257−273.10.3109/9781420017267 ↗
5. Wasan K. M. · Drug Dev. Ind. Pharm. · 2001 · 27 · 26710.1081/DDC-100103726 ↗
6. Hauss D. J. · Adv. Drug Delivery Rev. · 2007 · 59 · 66710.1016/j.addr.2007.05.006 ↗
7. Leggio C. · J. Phys. Chem. B · 2005 · 109 · 2385710.1021/jp053603b ↗
8. Roda A. · J. Biol. Chem. · 1983 · 258 · 636210.1016/S0021-9258(18)32418-9 ↗
9. Coello A. · J. Pharm. Sci. · 1996 · 85 · 910.1021/js950326j ↗
10. Matsuoka K. · Colloids Surf., B · 2003 · 32 · 8710.1016/S0927-7765(03)00148-6 ↗
11. Campredon M. · Magn. Reson. Chem. · 1986 · 24 · 62410.1002/mrc.1260240712 ↗
12. Conte G. · J. Phys. Chem. · 1984 · 88 · 572010.1021/j150667a052 ↗
13. Nair, P. P., Kritchevsky, D., and Setchell, K. D. R.The Bile Acids; Chemistry, Physiology, and Metabolism;Plenum Press:New York, 1971; p4 v.10.1007/978-1-4757-0647-5 ↗
14. Mazer N. A. · Biochemistry · 1979 · 18 · 306410.1021/bi00581a024 ↗
15. Oakenfull D. G. · J. Phys. Chem. · 1977 · 81 · 183810.1021/j100534a010 ↗
16. Marrink S. J. · J. Phys. Chem. B · 2000 · 104 · 183810.1021/jp001898h ↗
17. Tieleman D. P. · J. Phys. Chem. B · 2000 · 104 · 638010.1021/jp001268f ↗
18. Bond P. J. · J. Am. Chem. Soc. · 2004 · 126 · 1594810.1021/ja044819e ↗
19. Faeder J. · J. Phys. Chem. B · 2000 · 104 · 103310.1021/jp993076u ↗
20. Menger F. M. · Langmuir · 2007 · 23 · 230810.1021/la0633886 ↗
21. Marrink S. J. · Biochemistry · 2002 · 41 · 537510.1021/bi015613i ↗
22. Warren D. B. · Colloids Surf., A · 2006 · 280 · 18210.1016/j.colsurfa.2006.02.009 ↗
23. Partay L. B. · J. Phys. Chem. B · 2007 · 111 · 988610.1021/jp072974k ↗
24. Van Der Spoel D. · J. Comput. Chem. · 2005 · 26 · 170110.1002/jcc.20291 ↗
25. Schuttelkopf A. W. · Acta Crystallogr., Sect. D: Biol. Crystallogr. · 2004 · 60 · 135510.1107/S0907444904011679 ↗
26. Widom, B.Statistical Mechanics: A Concise Introduction for Chemists;Cambridge University Press:New York, 2002; pp339,102.10.1017/CBO9780511815836 ↗